Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Management of Severe Exacerbations of COPD or Asthma

COPD Exacerbations: Severity-Based Approach

  • For severe exacerbations of COPD, combination therapy with salbutamol and ipratropium is superior to salbutamol alone, according to the British Thoracic Society guidelines 1, 2
  • The American College of Chest Physicians confirms that combination therapy reduces the risk of acute exacerbations compared to albuterol alone (Grade 2B recommendation) 3
  • Combination therapy provides superior bronchodilation by targeting different receptors in the airways 3
  • Clinical benefits include improvements in quality of life, exercise tolerance, and lung function compared with monotherapy 3
  • For moderate exacerbations, either salbutamol or ipratropium bromide alone is appropriate as initial therapy, with nebulized bronchodilators given on arrival and at 4-6 hourly intervals thereafter 1, 2

Acute Severe Asthma: Clear Benefit of Combination

  • The American College of Allergy, Asthma, and Immunology confirms that ipratropium provides additive benefit in moderate or severe exacerbations, reducing hospitalizations especially in patients with severe airflow obstruction 5
  • For adults with severe asthma, treatment includes oxygen plus oral steroids plus nebulised salbutamol 5 mg, repeated 4-6 hourly if improving, with ipratropium bromide 500 µg added if not improving 4
  • For children with severe asthma, nebulised salbutamol 5 mg (or 0.15 mg/kg) is repeated 1-4 hourly if improving, with ipratropium bromide 250 µg added if not improving 4

Critical Administration Details for COPD Patients

  • In patients with CO2 retention and acidosis, nebulizers must be driven by compressed air, NOT oxygen, according to the British Thoracic Society guidelines 1, 2, 3
  • Oxygen can be continued via nasal prongs at 1-2 L/min during nebulization to prevent desaturation 1, 2
  • Do not give FiO2 >28% via Venturi mask or >2 L/min via nasal cannulae until arterial blood gases are known in patients with COPD history aged ≥50 years 1

Monitoring Requirements

  • Check blood gases within 60 minutes of starting oxygen and within 60 minutes of any change in inspired oxygen concentration 1
  • pH below 7.26 is predictive of poor outcome 1

Common Pitfalls to Avoid

  • Do not use combination therapy as first-line for moderate exacerbations - start with monotherapy and escalate if needed, according to the British Thoracic Society guidelines 1, 2
  • Do not power nebulizers with oxygen in hypercapnic COPD patients - use compressed air 1, 2, 3
  • Do not rely on nebulizer "dryness" as endpoint - continue until about one minute after "spluttering" occurs (5-10 minutes) 4
  • In patients with glaucoma, use mouthpiece rather than mask when administering ipratropium to avoid eye exposure 4, 6